Sign in

CIK 0001776111

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MBX Biosciences, Inc.

Sign in to watch
Ticker
MBX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 317-989-3100
Business address
11711 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46032
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$288,361
in 2 filings

Net −$288,361. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-04 Mathers Edward T Director Grant or award · Stock option (right to buy) +12,500 12,500
2025-06-05 Mathers Edward T Director Grant or award · Stock option (right to buy) +16,000 16,000
2024-09-16 Mathers Edward T Director Conversion +1,023,103 1,023,103
2024-09-16 Mathers Edward T Director Conversion +2,091,383 3,114,486
2024-09-16 Mathers Edward T Director Purchase +500,000 $16.00 $8.0M 3,614,486
2024-09-16 Mathers Edward T Director Conversion · Series A Convertible Preferred Stock −12,299,854 0
2024-09-16 Mathers Edward T Director Conversion · Series B Convertible Preferred Stock −25,142,840 0
2024-09-12 Mathers Edward T Director Grant or award · Stock Option (Right to Buy) +15,963 15,963

Page 1 of 1 · 8 trades